All product photos are real. Products are frosted due to cold climate storage technology. Tirzepatide is a novel synthetic peptide that serves as a dual agonist for both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These incretin hormones, released following nutrient intake, are crucial in maintaining glucose equilibrium by promoting insulin secretion. By harnessing the dual functionalities of GIP and GLP-1, tirzepatide builds on the successes of earlier GLP-1 receptor agonists like semaglutide, offering enhanced therapeutic potential across a range of applications.
Current Available Manufacturers:
QSC – TESTED – 32.2mg
XCE – TESTED -33.4mg
These products are not for human consumption and fall under research-only.
Reviews
There are no reviews yet.